AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimepye M 1mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Bluepipes Healthcare Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimepye M 1mg/500mg Tablet ER

Glimepyride/Metformin extended-release tablets (1mg/500mg) are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medication as prescribed, even if feeling well or experiencing controlled blood sugar, as discontinuation without medical consultation can lead to elevated blood glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms such as sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular meals and carry a fast-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be limited. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Disclose any history of heart disease to your physician prior to commencing treatment. Pregnant or breastfeeding individuals should consult their physician before use. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function may be recommended.

Uses of Glimepye M 1mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimepye M 1mg/500mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimepye M 1mg/500mg Extended-Release tablets with a meal.

Common Side effects of Glimepye M 1mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimepye M 1mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Consume the Glimepye M 1mg/500mg Extended-Release tablet with a meal.

How Glimepye M 1mg/500mg Tablet ER works:

Glimepye M ER tablets (1mg glimepiride/500mg metformin) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimepye M 1mg/500mg Tablet ER is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimepyride/Metformin 1mg/500mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the unborn. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glimepyride/Metformin 1mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimepye M 1mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of this medication. Regular kidney function monitoring is recommended during treatment. Physician consultation is advised.

LiverLiverCAUTION

Exercise caution when prescribing Glimepye M 1mg/500mg Extended-Release tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate treatment with a low Glimepye M 1mg/500mg Extended-Release tablet dose; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Glimepye M 1mg/500mg Tablet ER :

Should you forget a Glimepye M 1mg/500mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimepye M 1mg/500mg Tablet ER

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimepye M 1mg/500mg Tablet ER

Retain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Glimepye M 1mg/500mg Tablet ER can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this rare but potentially harmful side effect is particularly risky for individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms appear, discontinue Glimepye M 1mg/500mg Tablet ER use and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimepye M 1mg/500mg Extended-Release tablets, manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood sugar control when coupled with a healthy diet and exercise regimen. Glimepiride's action involves stimulating insulin secretion from the pancreas, thereby reducing blood glucose. Metformin functions by decreasing hepatic glucose production and increasing insulin responsiveness. This dual-drug therapy is unsuitable for type 1 DM.
Glimepye M 1mg/500mg Extended-Release tablets may cause common adverse reactions including low blood sugar, taste changes, nausea, abdominal discomfort, diarrhea, and headache. Rare but potentially severe side effects such as lactic acidosis are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, prolonged use of Glimepyride 1mg/500mg Extended-Release tablets can lead to Vitamin B12 deficiency. This medication disrupts Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications including paresthesia in the extremities, muscular weakness, urinary dysfunction, cognitive impairment, and ataxia. Prophylactic annual supplementation of Vitamin B12 is recommended by some experts to mitigate these risks.
Glimepyride/Metformin 1mg/500mg Extended-Release tablets can induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. These symptoms are more likely if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are concurrently used. Consequently, consistent blood glucose monitoring is crucial. Readily available glucose sources, such as glucose tablets, honey, or fruit juice, should always be kept on hand.
Combining Glimepye M 1mg/500mg Extended-Release tablets and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimepye M 1mg/500mg Tabl...
34
MRP 42
19% off